Next Article in Journal
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease
Next Article in Special Issue
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
Previous Article in Journal
Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation
Previous Article in Special Issue
Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany
 
 
Article

Article Versions Notes

Vaccines 2020, 8(4), 778; https://doi.org/10.3390/vaccines8040778
Action Date Notes Link
article xml file uploaded 19 December 2020 10:47 CET Original file -
article xml uploaded. 19 December 2020 10:47 CET Update https://www.mdpi.com/2076-393X/8/4/778/xml
article pdf uploaded. 19 December 2020 10:47 CET Version of Record https://www.mdpi.com/2076-393X/8/4/778/pdf
article html file updated 19 December 2020 10:48 CET Original file -
article html file updated 23 July 2022 06:02 CEST Update https://www.mdpi.com/2076-393X/8/4/778/html
Back to TopTop